Issue 7/2020
Content (12 Articles)
Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer
Pirus Ghadjar, Daniel M. Aebersold, Clemens Albrecht, Dirk Böhmer, Michael Flentje, Ute Ganswindt, Stefan Höcht, Tobias Hölscher, Arndt-Christian Müller, Peter Niehoff, Michael Pinkawa, Felix Sedlmayer, Daniel Zips, Thomas Wiegel
Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities
Stratos Vassis, Beatrice Nöldeke, Hans Christiansen, Christoph A. von Klot, Roland Merten
Linac-based stereotactic body radiation therapy for low and intermediate-risk prostate cancer
Ciro Franzese, Marco Badalamenti, Lucia Di Brina, Giuseppe D’Agostino, Davide Franceschini, Tiziana Comito, Elena Clerici, Pierina Navarria, Giacomo Reggiori, Pietro Mancosu, Stefano Tomatis, Marta Scorsetti
Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer+
Franco Campostrini, Andrea Remo, Laura Astati, Manuel Zorzi, Giulia Capodaglio, Alberto Buffoli, Gaia Moretti, Barbara Della Monica, Caterina Zanella, Giuseppe Verlato
Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer
Francesco Cuccia, Luca Nicosia, Rosario Mazzola, Vanessa Figlia, Niccolò Giaj-Levra, Francesco Ricchetti, Michele Rigo, Claudio Vitale, Stefanie Corradini, Ruggero Ruggieri, Filippo Alongi
PSMA-positive nodal recurrence in prostate cancer
Nina-Sophie Schmidt-Hegemann, Alexander Buchner, Chukwuka Eze, Paul Rogowski, Christian Schaefer, Harun Ilhan, Minglun Li, Wolfgang Peter Fendler, Peter Bartenstein, Ute Ganswindt, Christian Stief, Claus Belka, Alexander Kretschmer
Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients
Felix Böckelmann, Florian Putz, Karoline Kallis, Sebastian Lettmaier, Rainer Fietkau, Christoph Bert
Duration-dependent margins for prostate radiotherapy—a practical motion mitigation strategy
Eric Pei Ping Pang, Kellie Knight, Sung Yong Park, Weixiang Lian, Zubin Master, Marilyn Baird, Jason Wei Xiang Chan, Michael Lian Chek Wang, Terence Wee Kiat Tan, Melvin L. K. Chua, Eu Tiong Chua, Wen Shen Looi, Wen Long Nei, Jeffrey Kit Loong Tuan
An autoimmune-based, paraneoplastic neurologic syndrome following checkpoint inhibition and concurrent radiotherapy for merkel cell carcinoma: case report
Alexander D. Sherry, Michael Bezzerides, Mohamed H. Khattab, Guozhen Luo, Kristin K. Ancell, Austin N. Kirschner
Adjuvante Radiotherapie beim Niedrigrisikomammakarzinom: Langzeitergebnisse der ABCSG-8A-Studie
David Krug, Marciana-Nona Duma
Zirkulierende HPV-Tumor-DNA als möglicher Biomarker in der Rezidivdiagnostik des HPV-assoziierten Oropharynxkarzinoms
Alexander Rühle, Nils H. Nicolay